ArticleCancers2021

Effector Mechanisms of CD8+ HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy.

Rubén Osuna-Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.